(2021). Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. Int J Chron Obstruct Pulmon Dis, 16, 2591-2604. http://doi.org/10.2147/copd.s318969.
(2021). Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi-database cohort study with meta-analysis. Br J Clin Pharmacol, 87, 2589-2601. http://doi.org/10.1111/bcp.14669.
(2022). Long term impact of prophylactic antibiotic use before incision versus after cord clamping on children born by caesarean section: longitudinal study of UK electronic health records. Bmj, 377, e069704. http://doi.org/10.1136/bmj-2021-069704.
(2022). The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally representative retrospective cohort study, 2010-2019. Epidemiol Infect, 150, e107. http://doi.org/10.1017/s0950268822000838.
(2022). Suicide and death by other causes among patients with a severe mental illness: cohort study comparing risks among patients discharged from inpatient care v. those treated in the community. Epidemiol Psychiatr Sci, 31, e32. http://doi.org/10.1017/s2045796022000075.
(2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. Bmc Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6.
(2022). Left-sided heart failure burden and mortality in idiopathic pulmonary fibrosis: a population-based study. Bmc Pulm Med, 22, 190. http://doi.org/10.1186/s12890-022-01973-5.
(2022). A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis. Bmc Neurol, 22, 172. http://doi.org/10.1186/s12883-022-02692-4.
(2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495-510. http://doi.org/10.1002/pds.5419.
(2022). Association between Inhaled β(2)-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study. Int J Chron Obstruct Pulmon Dis, 17, 1205-1217. http://doi.org/10.2147/copd.s358927.